Literature DB >> 18275882

Aromatase inhibitors for infertility in polycystic ovary syndrome. The beginning or the end of a new era?

Nikolaos P Polyzos1, Maria Tsappi, Davide Mauri, Vedat Atay, Ivan Cortinovis, Giovanni Casazza.   

Abstract

A meta-analysis of four trials showed significant advantage in pregnancy and delivery rates with aromatase inhibitors compared with CC in women with PCOS. A recent randomized trial demonstrated no clear benefit.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18275882     DOI： 10.1016/j.fertnstert.2007.10.016

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  5 in total

Review 1.  Clinical review: The use of aromatase inhibitors for ovulation induction and superovulation.

Authors:  Mary Ellen Pavone; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2013-04-12       Impact factor: 5.958

Review 2.  The management of patients with polycystic ovary syndrome.

Authors:  Channa N Jayasena; Stephen Franks
Journal:  Nat Rev Endocrinol       Date:  2014-07-15       Impact factor: 43.330

3.  A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.

Authors:  Kallol Kumar Roy; Jinee Baruah; Shilpa Singla; Jai Bhagwan Sharma; Neeta Singh; Sunesh Kumar Jain; Manu Goyal
Journal:  J Hum Reprod Sci       Date:  2012-01

4.  Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate.

Authors:  Mohan S Kamath; Korula George
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211

Review 5.  Aromatase inhibitors in stimulated IVF cycles.

Authors:  Evangelos G Papanikolaou; Nikolaos P Polyzos; Peter Humaidan; George Pados; Ernesto Bosch; Herman Tournaye; Basil Tarlatzis
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.